These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22927451)

  • 1. Determinants of antiviral effectiveness in influenza virus A subtype H5N1.
    Chan PK; Lee N; Zaman M; Adisasmito W; Coker R; Hanshaoworakul W; Gasimov V; Oner AF; Dogan N; Tsang O; Phommasack B; Touch S; Bamgboye E; Swenson A; Toovey S; Dreyer NA
    J Infect Dis; 2012 Nov; 206(9):1359-66. PubMed ID: 22927451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H5N1 avian influenza in children.
    Oner AF; Dogan N; Gasimov V; Adisasmito W; Coker R; Chan PK; Lee N; Tsang O; Hanshaoworakul W; Zaman M; Bamgboye E; Swenson A; Toovey S; Dreyer NA
    Clin Infect Dis; 2012 Jul; 55(1):26-32. PubMed ID: 22423125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.
    Adisasmito W; Chan PK; Lee N; Oner AF; Gasimov V; Aghayev F; Zaman M; Bamgboye E; Dogan N; Coker R; Starzyk K; Dreyer NA; Toovey S
    J Infect Dis; 2010 Oct; 202(8):1154-60. PubMed ID: 20831384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between clinical features and prognosis of highly pathogenic avian influenza A/H5N1 infection in humans in mainland China].
    Li J; Xu Y; Chen YQ; Ge Y; Zhang LH; Xu XL; Wu TS; Chen YS; Wang J; Liu JN; Wei LP; Qiu C; Zhong XN; Huang MX; Xin JB; Luo RP; Zhao MS; Li ZQ; Hu CP; Zhao W; Wang H; Zhang W; Guo LS; Wang QY; Zhou LN; Liang ZA; Ma JQ; Liu YJ; Jiang YM; Xie WS; Sheng JF; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 May; 32(5):335-41. PubMed ID: 19799066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E; Ichihara K
    J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
    Taylor WR; Thinh BN; Anh GT; Horby P; Wertheim H; Lindegardh N; de Jong MD; Stepniewska K; Hanh TT; Hien ND; Bien NM; Chau NQ; Fox A; Ngoc NM; Crusat M; Farrar JJ; White NJ; Ha NH; Lien TT; Trung NV; Day N; Binh NG
    PLoS One; 2008; 3(10):e3410. PubMed ID: 18923671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Virology; 2013 Apr; 439(1):42-6. PubMed ID: 23453580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
    Leung YH; Lim WL; Wong MH; Chuang SK
    Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children.
    Sugaya N; Shinjoh M; Mitamura K; Takahashi T
    J Infect; 2011 Oct; 63(4):288-94. PubMed ID: 21722665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
    Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
    Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
    Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006.
    Vong S; Ly S; Van Kerkhove MD; Achenbach J; Holl D; Buchy P; Sorn S; Seng H; Uyeki TM; Sok T; Katz JM
    J Infect Dis; 2009 Jun; 199(12):1744-52. PubMed ID: 19416078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
    Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
    Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognizing true H5N1 infections in humans during confirmed outbreaks.
    Zaman M; Gasimov V; Oner AF; Dogan N; Adisasmito W; Coker R; Bamgboye EL; Chan PK; Hanshaoworakul W; Lee N; Phommasack B; Touch S; Tsang O; Swenson A; Toovey S; Dreyer NA
    J Infect Dev Ctries; 2014 Feb; 8(2):202-7. PubMed ID: 24518630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.